Search

everythinglearnresearchcommunity

for

Search:↓

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Metabolic syndrome linked to urinary symptoms; hair loss not significant.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Wnt signaling may be linked to heart diseases in aging and could be a target for future treatments.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

People with alopecia areata often have thyroid autoimmunity.

Kolaviron and quercetin may help treat prostate issues.

Exposure to toxic elements like mercury and lead may be linked to autism, and a higher zinc to copper ratio might help protect against it.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Obese women with PCOS are more likely to have fatty liver disease.

Gout should be managed by lowering uric acid levels, not just treating pain.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair growth and health are influenced by stress and hormones.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

The document concludes that hair analysis is not good for assessing nutrition but can detect long-term heavy metal exposure.

Understanding embryologic layers improves skin disorder diagnosis and supports developing targeted therapies.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.